ArticleHuman vaccines & immunotherapeutics2019

Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines.

Maria Petrecz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.